Patents Assigned to Connaught Technology Corporation
  • Patent number: 7255862
    Abstract: Recombinants containing and expressing lentivirus, retrovirus or immunodeficiency virus DNA and methods for making and using the same are disclosed and claimed. In an exemplified embodiment, attenuated recombinant viruses containing DNA encoding a feline immunodeficiency virus epitope such as an antigen, as well as methods and compositions employing the viruses, expression products therefrom, and antibodies generated from the viruses or expression products, are disclosed and claimed. The recombinants can be NYVAC or ALVAC recombinants. The DNA can encode at least one of: Env, Gag, Pol, or combinations thereof such as Gag and Pol or protease or Env, Gag and Pol or protease. The recombinants and gene products therefrom and antibodies generated by them have several preventive, therapeutic and diagnostic uses. DNA from the recombinants are useful as probes or, for generating PCR primers or for immunization.
    Type: Grant
    Filed: November 14, 1996
    Date of Patent: August 14, 2007
    Assignee: Connaught Technology Corporation
    Inventors: James Tartaglia, Enzo Paoletti
  • Patent number: 7144578
    Abstract: Recombinant viruses containing DNA coding for a rabies virus antigen, such as rabies virus G are disclosed and claimed. The recombinant viruses can be NYVAC or ALVAC recombinant viruses. The recombinant viruses and gene products therefrom are useful for eliciting an immunological against rabies virus, and, the gene products and antibodies elicited thereby are useful in assays.
    Type: Grant
    Filed: September 13, 2001
    Date of Patent: December 5, 2006
    Assignee: Connaught Technology Corporation
    Inventors: Enzo Paoletti, James Tartaglia, Jill Taylor, Russell Gettig